The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging

Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal, Phuoc T. Tran

Research output: Contribution to journalArticlepeer-review

Abstract

Historically, metastatic disease was thought to represent an all-or-nothing incurable state, distinct from curable localized disease and necessitating treatment with systemic therapy alone. The role for life-prolonging local therapy was known to be futile. This dogma was challenged in the 1990s with the reframing of metastasis as a spectrum rather than binary, resulting in the postulation of a low-volume metastatic state, given the term oligometastasis, which may actually be curable with definitive local therapy.

Original languageEnglish (US)
Pages (from-to)339-341
Number of pages3
JournalJournal of Nuclear Medicine
Volume63
Issue number3
DOIs
StatePublished - Mar 1 2022

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of 'The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging'. Together they form a unique fingerprint.

Cite this